Cargando…
In vivo Phage Display: A promising selection strategy for the improvement of antibody targeting and drug delivery properties
The discovery of hybridoma technology, described by Kohler and Milstein in 1975, and the resulting ability to generate monoclonal antibodies (mAbs) initiated a new era in antibody research and clinical development. However, limitations of the hybridoma technology as a routine antibody generation met...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549074/ https://www.ncbi.nlm.nih.gov/pubmed/36225354 http://dx.doi.org/10.3389/fmicb.2022.962124 |